{"id":{"repo_id":"cornell","oai_identifier":"oai:ecommons.cornell.edu:1813/103409"},"canonical_url":"https://search.ndltd.org/etd/cornell/oai:ecommons.cornell.edu:1813/103409","repository":{"repo_id":"cornell","name":"Cornell University","base_url":"https://ecommons.cornell.edu/server/oai/request"},"display":{"title":"VALIDATION AND IMPLEMENTATION OF VIBRATIONAL SPECTROSCOPIC MEASURES OF BONE COMPOSITION","abstract":"Bone composition, consisting of hydroxyapatite mineral and collagen matrix, can be altered by disrupted cellular remodeling processes and changes in serum chemistry, occurring with disease and drug treatments. Therefore, analysis of bone composition can contribute to the understanding of bone pathologies. FT-IR and Raman spectroscopy are two techniques to characterize the bone composition, although their outcomes are incompletely validated and understood. In addition, FT-IR and Raman spectroscopy can provide insight into the effects on bone tissue composition of active agents used to treat osteoporosis and diseases such as type 2 diabetes mellitus (T2DM), which are incompletely understood. Therefore, the objective of this dissertation was to validate FT-IR and Raman spectroscopic measures of bone composition and implement them to elucidate the role of osteoporosis treatments and T2DM on bone composition. In this dissertation, FT-IR and Raman bone mineral outcomes were validated against gold standard analytical measures in chemical standards and native tissue. Next, with a more complete understanding of these outcomes, Raman spectroscopy was applied in a pre-clinical murine study of anti-osteoporosis treatments. I demonstrated that sequential therapies decrease collagen maturity vs monotherapies, suggesting potentially improved bone material properties. Finally, FT-IR and Raman spectroscopy were applied in a translational study on clinical specimens from men with T2DM. Men with T2DM generally have similar bone composition, suggesting that the interaction between a robust cancellous compartment, characteristic to individuals with T2DM, and cortical bone may play a role in skeletal fragility in individuals with T2DM. The present work provides a quantitative foundation for researchers to apply FT-IR and Raman spectroscopy to characterize bone composition and demonstrates the ability of these techniques to contribute to the understanding of novel treatments for osteoporosis and skeletal fragility in men with T2DM.","abstract_html":"Bone composition, consisting of hydroxyapatite mineral and collagen matrix, can be altered by disrupted cellular remodeling processes and changes in serum chemistry, occurring with disease and drug treatments. Therefore, analysis of bone composition can contribute to the understanding of bone pathologies. FT-IR and Raman spectroscopy are two techniques to characterize the bone composition, although their outcomes are incompletely validated and understood. In addition, FT-IR and Raman spectroscopy can provide insight into the effects on bone tissue composition of active agents used to treat osteoporosis and diseases such as type 2 diabetes mellitus (T2DM), which are incompletely understood. Therefore, the objective of this dissertation was to validate FT-IR and Raman spectroscopic measures of bone composition and implement them to elucidate the role of osteoporosis treatments and T2DM on bone composition. In this dissertation, FT-IR and Raman bone mineral outcomes were validated against gold standard analytical measures in chemical standards and native tissue. Next, with a more complete understanding of these outcomes, Raman spectroscopy was applied in a pre-clinical murine study of anti-osteoporosis treatments. I demonstrated that sequential therapies decrease collagen maturity vs monotherapies, suggesting potentially improved bone material properties. Finally, FT-IR and Raman spectroscopy were applied in a translational study on clinical specimens from men with T2DM. Men with T2DM generally have similar bone composition, suggesting that the interaction between a robust cancellous compartment, characteristic to individuals with T2DM, and cortical bone may play a role in skeletal fragility in individuals with T2DM. The present work provides a quantitative foundation for researchers to apply FT-IR and Raman spectroscopy to characterize bone composition and demonstrates the ability of these techniques to contribute to the understanding of novel treatments for osteoporosis and skeletal fragility in men with T2DM.","abstract_has_math":false,"creators":["Taylor, Erik Arthur"],"institution":"Cornell University","degree_name":"Ph. D., Mechanical Engineering","degree_level":"Doctor of Philosophy","degree_discipline":"Mechanical Engineering","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":["Donnelly, Eve"],"committee_members":["Hernandez, Christopher J.","Estroff, Lara A."],"year":2020,"date_issued":"2020-12","date_published":"2020-12","updated_at":"2026-11-19T03:08:32Z","subjects":["bone mineral","FTIR spectroscpy","hydroxyapatite","osteoporosis","Raman spectroscopy","type 2 diabetes"],"languages":["en"],"rights":["Attribution-NonCommercial-NoDerivatives 4.0 International"],"rights_urls":["https://creativecommons.org/licenses/by-nc-nd/4.0/"],"identifier_entries":[{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.7298/czfd-dj21"],"render_values":[{"text":"https://doi.org/10.7298/czfd-dj21","href":"https://doi.org/10.7298/czfd-dj21","code":true}]},{"key":"dc:identifier.bibid","label":"Dc Identifier Bibid","values":["13312109"],"render_values":[{"text":"13312109","href":null,"code":true}]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["ProQuest Submission ID: 12386","ProQuest Publication ID: 28261275"],"render_values":[{"text":"ProQuest Submission ID: 12386","href":null,"code":true},{"text":"ProQuest Publication ID: 28261275","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/1813/103409","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/1813/103409","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://ecommons.cornell.edu/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aecommons.cornell.edu%3A1813%2F103409","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.chair","label":"Chair","values":["Donnelly, Eve"]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Hernandez, Christopher J.","Estroff, Lara A."]},{"key":"dc:creator","label":"Author","values":["Taylor, Erik Arthur"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2021-03-15T13:41:07Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2022-01-11T07:00:13Z"]},{"key":"dc:date.issued","label":"Date","values":["2020-12"]},{"key":"dc:relation.uri","label":"Dc Relation URI","values":["https://newcatalog.library.cornell.edu/catalog/13312109"]},{"key":"dc:type","label":"Dc Type","values":["dissertation or thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Mechanical Engineering"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Doctor of Philosophy"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph. D., Mechanical Engineering"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Cornell University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["bone mineral","FTIR spectroscpy","hydroxyapatite","osteoporosis","Raman spectroscopy","type 2 diabetes"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Attribution-NonCommercial-NoDerivatives 4.0 International"]},{"key":"dc:rights.uri","label":"Rights URI","values":["https://creativecommons.org/licenses/by-nc-nd/4.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.bibid","label":"Dc Identifier Bibid","values":["13312109"]},{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.7298/czfd-dj21"]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["ProQuest Submission ID: 12386","ProQuest Publication ID: 28261275"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/1813/103409"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"cerif:openaire","label":"Cerif Openaire","values":["<Publication xmlns=\"https://www.openaire.eu/cerif-profile/1.1/\" id=\"2bec3ebf-305f-4b97-bafc-9b01e64ead26\"> <Type xmlns=\"https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types\">http://purl.org/coar/resource_type/c_1843</Type> <Language>en</Language> <Title>VALIDATION AND IMPLEMENTATION OF VIBRATIONAL SPECTROSCOPIC MEASURES OF BONE COMPOSITION</Title> <PublishedIn> <Publication> </Publication> </PublishedIn> <PublicationDate>2020-12</PublicationDate> <DOI>https://doi.org/10.7298/czfd-dj21</DOI> <Authors> <Author> <DisplayName>Taylor, Erik Arthur</DisplayName> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <OrgUnit /> </Publisher> </Publishers> <License>https://creativecommons.org/licenses/by-nc-nd/4.0/</License> <Keyword>bone mineral</Keyword> <Keyword>FTIR spectroscpy</Keyword> <Keyword>hydroxyapatite</Keyword> <Keyword>osteoporosis</Keyword> <Keyword>Raman spectroscopy</Keyword> <Keyword>type 2 diabetes</Keyword> <Abstract>Bone composition, consisting of hydroxyapatite mineral and collagen matrix, can be altered by disrupted cellular remodeling processes and changes in serum chemistry, occurring with disease and drug treatments. Therefore, analysis of bone composition can contribute to the understanding of bone pathologies. FT-IR and Raman spectroscopy are two techniques to characterize the bone composition, although their outcomes are incompletely validated and understood. In addition, FT-IR and Raman spectroscopy can provide insight into the effects on bone tissue composition of active agents used to treat osteoporosis and diseases such as type 2 diabetes mellitus (T2DM), which are incompletely understood. Therefore, the objective of this dissertation was to validate FT-IR and Raman spectroscopic measures of bone composition and implement them to elucidate the role of osteoporosis treatments and T2DM on bone composition. In this dissertation, FT-IR and Raman bone mineral outcomes were validated against gold standard analytical measures in chemical standards and native tissue. Next, with a more complete understanding of these outcomes, Raman spectroscopy was applied in a pre-clinical murine study of anti-osteoporosis treatments. I demonstrated that sequential therapies decrease collagen maturity vs monotherapies, suggesting potentially improved bone material properties. Finally, FT-IR and Raman spectroscopy were applied in a translational study on clinical specimens from men with T2DM. Men with T2DM generally have similar bone composition, suggesting that the interaction between a robust cancellous compartment, characteristic to individuals with T2DM, and cortical bone may play a role in skeletal fragility in individuals with T2DM. The present work provides a quantitative foundation for researchers to apply FT-IR and Raman spectroscopy to characterize bone composition and demonstrates the ability of these techniques to contribute to the understanding of novel treatments for osteoporosis and skeletal fragility in men with T2DM.</Abstract> <Access xmlns=\"http://purl.org/coar/access_right\" > </Access> </Publication>"]},{"key":"cris:virtual.author","label":"Cris Virtual Author","values":["Taylor, Erik Arthur"]},{"key":"cris:virtualsource.collection","label":"Cris Virtualsource Collection","values":["5893a6ea-7af3-41d7-abc6-04bcd26ab5df"]},{"key":"dc:description","label":"Description","values":["321 pages"]},{"key":"dc:description.abstract","label":"Abstract","values":["Bone composition, consisting of hydroxyapatite mineral and collagen matrix, can be altered by disrupted cellular remodeling processes and changes in serum chemistry, occurring with disease and drug treatments. Therefore, analysis of bone composition can contribute to the understanding of bone pathologies. FT-IR and Raman spectroscopy are two techniques to characterize the bone composition, although their outcomes are incompletely validated and understood. In addition, FT-IR and Raman spectroscopy can provide insight into the effects on bone tissue composition of active agents used to treat osteoporosis and diseases such as type 2 diabetes mellitus (T2DM), which are incompletely understood. Therefore, the objective of this dissertation was to validate FT-IR and Raman spectroscopic measures of bone composition and implement them to elucidate the role of osteoporosis treatments and T2DM on bone composition. In this dissertation, FT-IR and Raman bone mineral outcomes were validated against gold standard analytical measures in chemical standards and native tissue. Next, with a more complete understanding of these outcomes, Raman spectroscopy was applied in a pre-clinical murine study of anti-osteoporosis treatments. I demonstrated that sequential therapies decrease collagen maturity vs monotherapies, suggesting potentially improved bone material properties. Finally, FT-IR and Raman spectroscopy were applied in a translational study on clinical specimens from men with T2DM. Men with T2DM generally have similar bone composition, suggesting that the interaction between a robust cancellous compartment, characteristic to individuals with T2DM, and cortical bone may play a role in skeletal fragility in individuals with T2DM. The present work provides a quantitative foundation for researchers to apply FT-IR and Raman spectroscopy to characterize bone composition and demonstrates the ability of these techniques to contribute to the understanding of novel treatments for osteoporosis and skeletal fragility in men with T2DM."]},{"key":"dc:description.collection","label":"Dc Description Collection","values":["Cornell Theses and Dissertations"]},{"key":"dc:format.mimetype","label":"Dc Format Mimetype","values":["application/pdf"]},{"key":"dcterms:license","label":"Dcterms License","values":["https://hdl.handle.net/1813/59810"]},{"key":"dc:title","label":"Title","values":["VALIDATION AND IMPLEMENTATION OF VIBRATIONAL SPECTROSCOPIC MEASURES OF BONE COMPOSITION"]},{"key":"dspace:entity.type","label":"Dspace Entity Type","values":["Publication"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"cerif:openaire":["<Publication xmlns=\"https://www.openaire.eu/cerif-profile/1.1/\" id=\"2bec3ebf-305f-4b97-bafc-9b01e64ead26\"> <Type xmlns=\"https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types\">http://purl.org/coar/resource_type/c_1843</Type> <Language>en</Language> <Title>VALIDATION AND IMPLEMENTATION OF VIBRATIONAL SPECTROSCOPIC MEASURES OF BONE COMPOSITION</Title> <PublishedIn> <Publication> </Publication> </PublishedIn> <PublicationDate>2020-12</PublicationDate> <DOI>https://doi.org/10.7298/czfd-dj21</DOI> <Authors> <Author> <DisplayName>Taylor, Erik Arthur</DisplayName> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <OrgUnit /> </Publisher> </Publishers> <License>https://creativecommons.org/licenses/by-nc-nd/4.0/</License> <Keyword>bone mineral</Keyword> <Keyword>FTIR spectroscpy</Keyword> <Keyword>hydroxyapatite</Keyword> <Keyword>osteoporosis</Keyword> <Keyword>Raman spectroscopy</Keyword> <Keyword>type 2 diabetes</Keyword> <Abstract>Bone composition, consisting of hydroxyapatite mineral and collagen matrix, can be altered by disrupted cellular remodeling processes and changes in serum chemistry, occurring with disease and drug treatments. Therefore, analysis of bone composition can contribute to the understanding of bone pathologies. FT-IR and Raman spectroscopy are two techniques to characterize the bone composition, although their outcomes are incompletely validated and understood. In addition, FT-IR and Raman spectroscopy can provide insight into the effects on bone tissue composition of active agents used to treat osteoporosis and diseases such as type 2 diabetes mellitus (T2DM), which are incompletely understood. Therefore, the objective of this dissertation was to validate FT-IR and Raman spectroscopic measures of bone composition and implement them to elucidate the role of osteoporosis treatments and T2DM on bone composition. In this dissertation, FT-IR and Raman bone mineral outcomes were validated against gold standard analytical measures in chemical standards and native tissue. Next, with a more complete understanding of these outcomes, Raman spectroscopy was applied in a pre-clinical murine study of anti-osteoporosis treatments. I demonstrated that sequential therapies decrease collagen maturity vs monotherapies, suggesting potentially improved bone material properties. Finally, FT-IR and Raman spectroscopy were applied in a translational study on clinical specimens from men with T2DM. Men with T2DM generally have similar bone composition, suggesting that the interaction between a robust cancellous compartment, characteristic to individuals with T2DM, and cortical bone may play a role in skeletal fragility in individuals with T2DM. The present work provides a quantitative foundation for researchers to apply FT-IR and Raman spectroscopy to characterize bone composition and demonstrates the ability of these techniques to contribute to the understanding of novel treatments for osteoporosis and skeletal fragility in men with T2DM.</Abstract> <Access xmlns=\"http://purl.org/coar/access_right\" > </Access> </Publication>"],"cris:virtual.author":["Taylor, Erik Arthur"],"cris:virtualsource.collection":["5893a6ea-7af3-41d7-abc6-04bcd26ab5df"],"dc:contributor.chair":["Donnelly, Eve"],"dc:contributor.committeemember":["Hernandez, Christopher J.","Estroff, Lara A."],"dc:creator":["Taylor, Erik Arthur"],"dc:date.accessioned":["2021-03-15T13:41:07Z"],"dc:date.available":["2022-01-11T07:00:13Z"],"dc:date.issued":["2020-12"],"dc:description":["321 pages"],"dc:description.abstract":["Bone composition, consisting of hydroxyapatite mineral and collagen matrix, can be altered by disrupted cellular remodeling processes and changes in serum chemistry, occurring with disease and drug treatments. Therefore, analysis of bone composition can contribute to the understanding of bone pathologies. FT-IR and Raman spectroscopy are two techniques to characterize the bone composition, although their outcomes are incompletely validated and understood. In addition, FT-IR and Raman spectroscopy can provide insight into the effects on bone tissue composition of active agents used to treat osteoporosis and diseases such as type 2 diabetes mellitus (T2DM), which are incompletely understood. Therefore, the objective of this dissertation was to validate FT-IR and Raman spectroscopic measures of bone composition and implement them to elucidate the role of osteoporosis treatments and T2DM on bone composition. In this dissertation, FT-IR and Raman bone mineral outcomes were validated against gold standard analytical measures in chemical standards and native tissue. Next, with a more complete understanding of these outcomes, Raman spectroscopy was applied in a pre-clinical murine study of anti-osteoporosis treatments. I demonstrated that sequential therapies decrease collagen maturity vs monotherapies, suggesting potentially improved bone material properties. Finally, FT-IR and Raman spectroscopy were applied in a translational study on clinical specimens from men with T2DM. Men with T2DM generally have similar bone composition, suggesting that the interaction between a robust cancellous compartment, characteristic to individuals with T2DM, and cortical bone may play a role in skeletal fragility in individuals with T2DM. The present work provides a quantitative foundation for researchers to apply FT-IR and Raman spectroscopy to characterize bone composition and demonstrates the ability of these techniques to contribute to the understanding of novel treatments for osteoporosis and skeletal fragility in men with T2DM."],"dc:description.collection":["Cornell Theses and Dissertations"],"dc:format.mimetype":["application/pdf"],"dc:identifier.bibid":["13312109"],"dc:identifier.doi":["https://doi.org/10.7298/czfd-dj21"],"dc:identifier.other":["ProQuest Submission ID: 12386","ProQuest Publication ID: 28261275"],"dc:identifier.uri":["https://hdl.handle.net/1813/103409"],"dc:language.iso":["en"],"dc:relation.uri":["https://newcatalog.library.cornell.edu/catalog/13312109"],"dc:rights":["Attribution-NonCommercial-NoDerivatives 4.0 International"],"dc:rights.uri":["https://creativecommons.org/licenses/by-nc-nd/4.0/"],"dc:subject":["bone mineral","FTIR spectroscpy","hydroxyapatite","osteoporosis","Raman spectroscopy","type 2 diabetes"],"dcterms:license":["https://hdl.handle.net/1813/59810"],"dc:title":["VALIDATION AND IMPLEMENTATION OF VIBRATIONAL SPECTROSCOPIC MEASURES OF BONE COMPOSITION"],"dc:type":["dissertation or thesis"],"dspace:entity.type":["Publication"],"others:access_status":["open.access"],"thesis:degree_discipline":["Mechanical Engineering"],"thesis:degree_level":["Doctor of Philosophy"],"thesis:degree_name":["Ph. D., Mechanical Engineering"],"thesis:institution_name":["Cornell University"]},"updated_at":"2026-11-19T03:08:32Z"}